Thomas Harding - Mar 1, 2022 Form 4 Insider Report for Clovis Oncology, Inc. (CLVS)

Role
Executive Vice President and Chief Scientific Officer
Signature
/s/ Thomas Harding
Stock symbol
CLVS
Transactions as of
Mar 1, 2022
Transactions value $
-$14,603
Form type
4
Date filed
3/3/2022, 03:15 PM
Previous filing
Feb 3, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLVS Common Stock Options Exercise +282 +4.19% 7.02K Mar 1, 2022 Direct F1
transaction CLVS Common Stock Sale -$310 -166 -2.37% $1.87* 6.85K Mar 2, 2022 Direct F2, F3
transaction CLVS Common Stock Options Exercise +11.6K +169.11% 18.4K Mar 1, 2022 Direct F1
transaction CLVS Common Stock Sale -$12.7K -6.78K -36.78% $1.87* 11.7K Mar 2, 2022 Direct F2, F3
transaction CLVS Common Stock Options Exercise +19 +1.15% 1.67K Mar 1, 2022 By wife F1
transaction CLVS Common Stock Sale -$17 -9 -0.54% $1.87* 1.66K Mar 2, 2022 By wife F2, F4
transaction CLVS Common Stock Options Exercise +2.03K +122.2% 3.69K Mar 1, 2022 By wife F1
transaction CLVS Common Stock Sale -$1.63K -871 -23.59% $1.87* 2.82K Mar 2, 2022 By wife F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLVS Restricted Stock Units Award $0 +81K $0.00 81K Mar 1, 2022 Common Stock 81K Direct F1, F5
transaction CLVS Restricted Stock Units Award $0 +6.38K $0.00 6.38K Mar 1, 2022 Common Stock 6.38K By wife F1, F6
transaction CLVS Restricted Stock Units Options Exercise $0 +11.6K +50% $0.00 34.8K Mar 1, 2022 Common Stock 11.6K Direct F1, F7
transaction CLVS Restricted Stock Units Options Exercise $0 +282 $0.00* 0 Mar 1, 2022 Common Stock 282 Direct F1, F8
transaction CLVS Restricted Stock Units Options Exercise $0 +19 $0.00* 0 Mar 1, 2022 Common Stock 19 By wife F1, F9
transaction CLVS Restricted Stock Units Options Exercise $0 +2.03K +100% $0.00 4.06K Mar 1, 2022 Common Stock 2.03K By wife F1, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the right to receive one share of Common Stock.
F2 Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person.
F3 This transaction was executed in multiple trades at prices ranging from $1.860 to $1.866. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $1.861 to $1.866. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 The Restricted Stock Units shall vest as to 25% of the units on March 1, 2023, and the remainder shall vest in substantially equal installments over the 12 quarters immediately following such date.
F6 The Restricted Stock Units shall vest as to 33.3% of the units on March 1, 2023, and the remainder shall vest in substantially equal installments over the 8 quarters immediately following such date.
F7 On March 1, 2021, the reporting person was granted 46,334 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
F8 On March 1, 2018, the reporting person was granted 4,500 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
F9 On March 1, 2018, the reporting person's wife was granted 297 Restricted Stock Units. 25% of such Restricted Stock Units vested on March 1, 2019, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
F10 On March 1, 2021, the reporting person's wife was granted 6,090 Restricted Stock Units. 33.3% of such Restricted Stock Units vested on March 1, 2022, and the remainder vests in substantially equal installments over the 8 quarters immediately following such date.

Remarks:

Executive Vice President and Chief Scientific Officer